Zogenix
Developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with rare diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$60—90m (Dealroom.co estimates Jul 2010.)
Share price
€23.65 ZGNX
Emeryville California (HQ)
Authorizing premium user...